Nadler Financial Group’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Hold |
4,939
| – | – | 0.02% | 115 |
|
|
2025
Q1 | $252K | Hold |
4,939
| – | – | 0.03% | 105 |
|
|
2024
Q4 | $223K | Buy |
+4,939
| New | +$223K | 0.02% | 116 |
|
|
2023
Q3 | – | Sell |
-4,939
| Closed | -$201K | – | 115 |
|
|
2023
Q2 | $201K | Hold |
4,939
| – | – | 0.03% | 111 |
|
|
2023
Q1 | $239K | Buy |
+4,939
| New | +$239K | 0.04% | 96 |
|
|
2022
Q4 | – | Sell |
-4,939
| Closed | -$248K | – | 114 |
|
|
2022
Q3 | $248K | Buy |
+4,939
| New | +$248K | 0.05% | 85 |
|
|
2022
Q2 | – | Sell |
-6,413
| Closed | -$239K | – | 117 |
|
|
2022
Q1 | $239K | Hold |
6,413
| – | – | 0.04% | 103 |
|
|
2021
Q4 | $255K | Hold |
6,413
| – | – | 0.04% | 105 |
|
|
2021
Q3 | $239K | Hold |
6,413
| – | – | 0.04% | 105 |
|
|
2021
Q2 | $271K | Hold |
6,413
| – | – | 0.04% | 104 |
|
|
2021
Q1 | $304K | Hold |
6,413
| – | – | 0.05% | 84 |
|
|
2020
Q4 | $391K | Hold |
6,413
| – | – | 0.07% | 72 |
|
|
2020
Q3 | $300K | Hold |
6,413
| – | – | 0.07% | 78 |
|
|
2020
Q2 | $325K | Hold |
6,413
| – | – | 0.08% | 72 |
|
|
2020
Q1 | $286K | Hold |
6,413
| – | – | 0.09% | 66 |
|
|
2019
Q4 | $308K | Hold |
6,413
| – | – | 0.08% | 71 |
|
|
2019
Q3 | $217K | Buy |
+6,413
| New | +$217K | 0.06% | 77 |
|